Shares in Intersect ENT (NSDQ:XENT) held steady today after the company reported preliminary data for its fourth quarter and full-year revenues. The Menlo Park, Calif.-based company said it expects to reel in $96.1 – $96.3 million in revenue for the full year of 2017, up 22% from 2016. Intersect also pegged its fourth-quarter revenue between $29.3 million […]
MassDevice Earnings Roundup
Wright Medical shares rise on Q4, FY2017 prelims
Wright Medical (NSDQ:WMGI) today saw shares rise slightly after it announced preliminary earnings for the fourth quarter and full-year 2017 earnings results that beat The Street. The Amsterdam-based company said it expects to post fourth quarter sales of approximately $217.6 million, which tops analysts expectations of $215.1 million for the quarter. That represents growth of 12.7% […]
NuVasive takes a dive on Q4 prelims
NuVasive Inc. (NSDQ:NUVA) shares took a hit today after the company posted preliminary results for the fourth quarter, disappointing analysts who were expecting better numbers from the spinal implant maker. San Diego-based NuVasive reported preliminary Q4 sales of $272 million and preliminary full-year sales of $1.03 billion, roughly in line with the consensus on Wall Street. […]
AngioDynamics shares fall on Q2 sales miss
Shares in AngioDynamics (NSDQ:ANGO) have fallen today after the medical device maker missed sales expectations, despite nailing earnings per share expectations, with its second quarter fiscal 2018 earnings results. The Latham, N.Y.-based company posted profits of $249,000, or 1¢ per share, on sales of $86.7 million for the three months ended November 30, 2017, seeing the […]
Elekta delays rollout for Unity MR-radiation therapy combo
Elekta (STO:EKTA B) today said it’s delaying the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needs more time to finalize and validate the linac control system. The Swedish company said the decision means it’s postponing its bid for CE Mark approval in the […]
Medigus prices $2m direct placement, releases Q3 earnings
Medigus (TLV:MDGS) late last week priced a $1.6 million direct placement and released its third quarter earnings, seeing operating losses drop compared with the same period during the previous year. In its direct placement, the company said it is offering 810,000 American depository shares at approximately $2 per ADS alongside unregistered warrants to purchase an additional […]
NxStage shares dip on Q3 EPS miss
Shares in NxStage Medical (NSDQ:NXTM) have fallen slightly today after the medical device maker missed expectations on Wall Street with its third quarter earnings results. The Lawrence, Mass.-based company posted losses of $8.9 million, or 14¢ per share, on sales of $97.3 million for the 3 months ended September 30, seeing losses grow nearly 900% while […]
UPDATE: Medtronic’s fiscal Q2 tops The Street
UPDATED November 21, 2017, with segment results, share prices Medtronic (NYSE:MDT) posted fiscal second-quarter numbers that beat both sales and earnings forecasts on Wall Street, after a better-than-expected recovery from Hurricane Maria. The Fridley, Minn.-based medical device giant reported profits of $2.02 billion, or $1.48 per share, on sales of $7.05 billion for the three […]
Shares in Delcath fall after losses grow in Q3
Shares in Delcath Systems (NSDQ:DCTHD) crashed today after the company posted its third quarter results, revealing that the company’s net losses have grown dramatically quarter-over-quarter. The N.Y.-based company posted a net loss of -$12.6 million on sales of $684,000 for the 3 months ended Sept. 30, for sales growth of 57% compared with the same period last year. […]
Pavmed shares climb after Q3 EPS beat
Shares in Pavmed Inc. (NSDQ:PAVM) rose today after the medical device maker beat expectations on Wall Street with its third quarter results. The N.Y.-based company posted a net loss of -$5.37 million, or -40¢ per share, for the 3 months ended Sept. 30, for bottom-line loss of -178.5% compared with the same period last year. Get the […]
Neovasc shares fall on Q3 sales miss
Shares in Neovasc (NSDQ:NVCN) have risen in early morning trading today after the medical device maker posted 2nd quarter earnings that beat the Street on losses per share but missed on sales. The Vancouver-based company posted losses of $5.8 million, or 6¢ per share, on sales of $1.4 million for the 3 months ended September 30, […]